Comparison of Two Respiratory Physiotherapy Treatments in Postcovid-19 Patients. Randomiced Clinical Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- Universidad Católica de Ávila
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- peak expiratory pressure
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
To test the effectiveness of a respiratory physiotherapy treatment plan in patients who have passed COVID-19, comparing two randomized groups, for the performance of different respiratory musculature training protocols. To objectify the results data obtained by means of ultrasound measurements and spirometry, observing the differences obtained at the beginning and end of the study, verifying the effectiveness of the PowerBreathe® ,Therosold PEP® tools and the effectiveness of diaphragmatic, abdominal and expiratory exercises.
Investigators
JORGE VELAZQUEZ SAORNIL
Principal Investigator
Universidad Católica de Ávila
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed with Covid and suffering from functional limitations in the respiratory system.
- •Patients over 18 years of age.
- •Patients under 65 years of age.
- •Patientes with cognitive ability to perform spirometry.
- •Patients with the physical capacity to perform spirometry
Exclusion Criteria
- •- Patients diagnosed with Covid and without functional limitations in the respiratory system.
- •Patients under 18 years of age.
- •Patients over 65 years of age.
- •Patients without cognitive capacity to perform spirometry.
- •Patients without physical capacity to perform spirometry.
Outcomes
Primary Outcomes
peak expiratory pressure
Time Frame: 1 month
0 miminum ,200 maximum
peak inspiratory pressure (PIM)
Time Frame: 1 month
0 miminum ,200 maximum
forced vital capacity
Time Frame: 1 month
0 miminum ,200 maximum